Proceedings from a webinar on July 1, 2026, moderated by Dr Neil Love. Published September 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 1.25 credits
MOC types
ABS — Accredited CMEUp to 1.25 pointsABIM — Medical KnowledgeUp to 1.25 pointsABS — Self-AssessmentUp to 1.25 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 1.25 credits
- MOC · Up to 1.25 points
-
ReleasedSep 3, 2026
-
Last day to claim creditSep 5, 2027 11 months left
-
Research to Practice Consensus or Controversy? Clinical Investigators Discuss and Debate Current Approaches to First- and Second-Line Therapy for HR-Positive mBC | 2026 (Webinar Proceedings)
-
Research to Practice Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Localized HR-Positive Breast Cancer | 2026 (Webinar Proceedings)
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing Biomarker Assessment and Related Treatment Decision-Making for Patients with HR-Positive mBC | 2026 (Video Lecture)
-
Medscape, LLC HER2-Positive MBC: A Community Oncologist’s Guide to Treatment Optimization
-
Answers in CME Inc. (AiCME) Refining Care for HR+, HER2+ mBC in the Community: Contextualizing the Data for Emerging First-Line Maintenance Therapies
-
Physicians’ Education Resource Module 3: HR+/HER2- Breast Cancer
